Granahan Investment Management’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,243,842
| Closed | -$11.4M | – | 213 |
|
|
2021
Q2 | $11.4M | Buy |
1,243,842
+412,813
| +50% | +$3.79M | 0.21% | 105 |
|
|
2021
Q1 | $4.13M | Buy |
831,029
+78,207
| +10% | +$389K | 0.09% | 152 |
|
|
2020
Q4 | $3.25M | Sell |
752,822
-146,186
| -16% | -$630K | 0.07% | 153 |
|
|
2020
Q3 | $3.86M | Buy |
899,008
+7,467
| +0.8% | +$32K | 0.13% | 122 |
|
|
2020
Q2 | $4M | Sell |
891,541
-29,052
| -3% | -$130K | 0.14% | 114 |
|
|
2020
Q1 | $3.68M | Buy |
920,593
+156,694
| +21% | +$627K | 0.2% | 98 |
|
|
2019
Q4 | $6.48M | Buy |
763,899
+21,625
| +3% | +$183K | 0.3% | 80 |
|
|
2019
Q3 | $5.09M | Buy |
742,274
+40,997
| +6% | +$281K | 0.28% | 86 |
|
|
2019
Q2 | $5.84M | Sell |
701,277
-9,513
| -1% | -$79.2K | 0.29% | 81 |
|
|
2019
Q1 | $6.52M | Sell |
710,790
-74,072
| -9% | -$679K | 0.35% | 76 |
|
|
2018
Q4 | $8.59M | Buy |
784,862
+152,744
| +24% | +$1.67M | 0.61% | 60 |
|
|
2018
Q3 | $8.82M | Buy |
632,118
+313,377
| +98% | +$4.37M | 0.48% | 69 |
|
|
2018
Q2 | $3.4M | Buy |
318,741
+153,479
| +93% | +$1.63M | 0.2% | 124 |
|
|
2018
Q1 | $1.43M | Buy |
165,262
+38,744
| +31% | +$335K | 0.1% | 159 |
|
|
2017
Q4 | $1.2M | Buy |
126,518
+40,160
| +47% | +$380K | 0.09% | 162 |
|
|
2017
Q3 | $678K | Buy |
86,358
+22,768
| +36% | +$179K | 0.06% | 163 |
|
|
2017
Q2 | $547K | Buy |
+63,590
| New | +$547K | 0.05% | 165 |
|